"The approval represents yet another major milestone for the Goulamina project. Clearly the outcomes of the DFS update have been extremely compelling to the boards of both companies and it is a testimony to the project's credentials that the partners have moved so quickly and collaboratively to commit to the development of Goulamina," says Firefinch MD Dr Michael Anderson.